Anidulafungin Vicuron
Martin-Mazuelos, E.
Idrugs the Investigational Drugs Journal 6(10): 980-986
2003
ISSN/ISBN: 1369-7056 PMID: 14534856 Document Number: 556667
Anidulafungin, a 1,3-beta-glucan synthesis inhibitor and the pentyloxyterphenyl side chain derivative of echinocandin B, is being developed by Vicuron Pharmaceuticals Inc, under license from Eli Lilly & Co, for the potential treatment of fungal infection.